Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 276901 | ||
| 1:53 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027--
Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow

Enzon Reveals New LNA Targets
-- Data will be presented at upcoming American Association for Cancer Research Meeting--
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
